scout
|Videos|May 11, 2017

Indoximod as an Active IDO Pathway Inhibitor in Melanoma

Yousef Zakharia, MD, assistant professor, University of Iowa, Holden Comprehensive Cancer Center, discusses indoximod as an active IDO inhibitor in advanced melanoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME